Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
A California judge on Monday slashed roughly $211 million from the $289 million jury verdict won by a groundskeeper who alleged that Monsanto’s Roundup weedkiller caused his lymphoma, ruling that the jury’s punitive damages award must be limited to protect the agrochemical giant’s due process rights.
The full Federal Circuit on Monday said it won't reconsider a panel’s ruling that tribes can face Patent Trial and Appeal Board scrutiny, likely paving the way for one of the court’s closest-watched cases to head to the U.S. Supreme Court.
A Kentucky-based medical equipment company will pony up more than $5.25 million to end accusations that it made false statements about the contents of its compounded medical creams, the federal government announced on Monday.
A group of medical testing labs urged a Texas federal judge Friday to toss a $44 million suit brought by UnitedHealthcare Insurance Co., saying payments made by the insurer weren't fraudulent and were federally mandated through the Employee Retirement Income Security Act.
Desmarais LLP has added as partners in its life sciences practice a pair of experienced attorneys from Sidley Austin with a specialty in representing pharmaceutical patent holders in Hatch-Waxman Act cases, the firm has announced.